used in combination with prednisone in metastatic castration-resistant prostate cancer (formerly hormoneresistant or hormone-refractory prostate cancer) - i.e., prostate cancer not responding to androgen deprivation or treatment with antiandrogens.
Uses: metastatic castration-resistant prostate cancer (CRPC) in patients who are chemotherapy-I or in those who have received prior chemotherapy containing docetaxel; administer with prednisone 4tabs (1000mg) PO qDay with prednisone 5mg PO q12hr.
Tablets
21685 EGP
used in combination with prednisone in metastatic castration-resistant prostate cancer (formerly hormoneresistant or hormone-refractory prostate cancer) - i.e., prostate cancer not responding to androgen deprivation or treatment with antiandrogens.
Uses: metastatic castration-resistant prostate cancer (CRPC) in patients who are chemotherapy-I or in those who have received prior chemotherapy containing docetaxel; administer with prednisone 4tabs (1000mg) PO qDay with prednisone 5mg PO q12hr.
Note: All the provided information about this drug does not substitute for consulting a doctor.